FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileVirtus LifeSci Biotech Products ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
BBP
Virtus LifeSci Biotech Products ETF ETF AnalysisComprehensive ETF analysis for Virtus LifeSci Biotech Products ETF (BBP) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisBBP
BBP
Virtus LifeSci Biotech Products ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
BBP
  1. Home
  2. Screener
  3. Virtus LifeSci Biotech Products ETFBBPETF

Virtus LifeSci Biotech Products ETF

ETF
🇺🇸BBP•AMEX•Sector Equity
Fund size (USD)
$133.09M
Expense Ratio
0.34%
Holdings
198

Your view on BBP

Virtus LifeSci Biotech Products ETF

ETFVirtus
🇺🇸BBP•AMEX•Sector Equity
Fund size (USD)
$133.09M
Expense Ratio
0.34%
Holdings
198
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Virtus LifeSci Biotech Products ETF (BBP) is a Sector Equity fund from Virtus, listed since 2014, with $133.1M in assets under management, a 0.34% expense ratio and a NAV of $102.38 USD.

Overview for Virtus LifeSci Biotech Products ETF

Fund Type
ETF
Fund Issuer
Virtus
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 16, 2014
Domicile
US
Website
virtus.com/products/virtus-biotech-etf#shareclass./period.quarterly
Fund Type
ETF
Fund Issuer
Virtus
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 16, 2014
Domicile
US
Website
virtus.com/products/virtus-biotech-etf#shareclass./period.quarterly
Fund Type
ETF
Fund Issuer
Virtus
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
December 16, 2014
Domicile
US
Website
virtus.com/products/virtus-biotech-etf#shareclass./period.quarterly

About this fund

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Sector Equity

Expense Ratio

0.34%

Fund size

$133.09M

Fund Details

NAV$102.38 USD
Holdings198
Average Volume11.7K
Inception DateDecember 16, 2014
Asset ClassSector Equity
Fund IssuerVirtus
DomicileUS
ISINUS26923G2021
CUSIP26923G202
NAV CurrencyUSD

Expense Ratio

0.34%

Assets Under Management

$133.09M

NAV

$102.38 USD

Holdings

198

Average Volume

11.7K

Inception Date

December 16, 2014

Asset Class

Sector Equity

Fund Issuer

Virtus

Domicile

US

ISIN

US26923G2021

CUSIP

26923G202

NAV Currency

USD

Expense Ratio

0.34%

Assets Under Management

$133.09M

NAV

$102.38 USD

Holdings

198

Average Volume

11.7K

Inception Date

December 16, 2014

Asset Class

Sector Equity

Fund Issuer

Virtus

Domicile

US

ISIN

US26923G2021

CUSIP

26923G202

NAV Currency

USD

Data last updated: Nov 15, 2026, 08:11 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

67 positions
1MRNAModerna Inc
5.55%
2XERSXeris Biopharma Holdings Inc
3.40%
3KNSAKiniksa Pharmaceuticals International Plc
2.51%
4IOVAIovance Biotherapeutics Inc
2.49%
5VSTMVerastem Inc
2.33%
6ADMAADMA Biologics Inc
2.26%
7OMEROmeros Corp
2.23%
8BGNEBeOne Medicines Ltd
2.10%
9REGNRegeneron Pharmaceuticals Inc
2.09%
10INSMInsmed Inc
2.05%
11HALOHalozyme Therapeutics Inc
1.86%
12GILDGilead Sciences Inc
1.84%
13RYTMRhythm Pharmaceuticals Inc
1.84%
14TGTXTG Therapeutics Inc
1.82%
15ROIVRoivant Sciences Ltd
1.80%

Concentration

Top 10 Weight27.02%
1MRNAModerna Inc
5.55%
2XERSXeris Biopharma Holdings Inc
3.40%
3KNSAKiniksa Pharmaceuticals International Plc
2.51%
4IOVAIovance Biotherapeutics Inc
2.49%
5VSTMVerastem Inc
2.33%
6ADMAADMA Biologics Inc
2.26%
7OMEROmeros Corp
2.23%
8BGNEBeOne Medicines Ltd
2.10%
9REGNRegeneron Pharmaceuticals Inc
2.09%
10INSMInsmed Inc
2.05%
11HALOHalozyme Therapeutics Inc
1.86%
12GILDGilead Sciences Inc
1.84%
13RYTMRhythm Pharmaceuticals Inc
1.84%
14TGTXTG Therapeutics Inc
1.82%
15ROIVRoivant Sciences Ltd
1.80%

Top 10 Weight

27.02%

1MRNAModerna Inc
5.55%$7.00M
2XERSXeris Biopharma Holdings Inc
3.40%$4.29M
3KNSAKiniksa Pharmaceuticals International Plc
2.51%$3.16M
4IOVAIovance Biotherapeutics Inc
2.49%$3.14M
5VSTMVerastem Inc
2.33%$2.93M
6ADMAADMA Biologics Inc
2.26%$2.85M
7OMEROmeros Corp
2.23%$2.81M
8BGNEBeOne Medicines Ltd
2.10%$2.65M
9REGNRegeneron Pharmaceuticals Inc
2.09%$2.64M
10INSMInsmed Inc
2.05%$2.59M
11HALOHalozyme Therapeutics Inc
1.86%$2.35M
12GILDGilead Sciences Inc
1.84%$2.32M
13RYTMRhythm Pharmaceuticals Inc
1.84%$2.32M
14TGTXTG Therapeutics Inc
1.82%$2.30M
15ROIVRoivant Sciences Ltd
1.80%$2.27M

Top 10 Weight

27.02%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
BBPVirtus LifeSci Biotech Products ETFThis fundSector Equity0.34%$133M198

Comparable funds

  • CPROCalamos Russell 2000 Structured Alt Protection ETF – OctoberEquity0.69%$27M5
  • EMMGlobal X - Emerging Markets ex-China ETFEquity0.66%$54M43
  • GAEMSimplify Gamma Emerging Market Bond ETFFixed Income0.96%$40M44
  • GKAdvisorShares Gerber Kawasaki ETFEquity1.27%$29M32
  • HSMVFirst Trust Horizon Managed Volatility Small/Mid ETFSmall/Micro Cap Equity0.80%$6M151
  • LFEQVanEck Long/Flat Trend ETFEquity0.58%$27M2
  • MARTAllianzIM U.S. Equity Buffer10 Mar ETFEquity0.74%$29M5
  • MMSCFirst Trust Multi-Manager Small Cap Opportunities ETFSmall/Micro Cap Equity0.95%$51M190

More Virtus ETFs

  • JOETVirtus Terranova U.S. Quality Momentum ETFUS Equity0.29%$227M198
  • KMIDVirtus KAR Mid-Cap ETFUS Equity0.80%$53M217
  • NFLTVirtus Newfleet Multi-Sector Bond ETFFixed Income0.50%$568M198
  • PFFAVirtus InfraCap U.S. Preferred Stock ETFCore Investment Grade Bond2.11%$2.2B198
  • PFFRInfraCap REIT Preferred ETFReal Estate (Listed/REITs)0.45%$108M110
  • SDCPVirtus Newfleet Short Duration Core Plus Bond ETFFixed Income0.35%$13M198
  • SEIXVirtus Seix Senior Loan ETFHigh Yield & Loans0.57%$307M198
  • SSMGVirtus Silvant Small/Mid Growth ETFUS Equity0.39%$3M82
  • UTESVirtus Reaves Utilities ETFAlternatives0.49%$1.1B198
  • VABSVirtus Newfleet Securitized Income ETFCore Investment Grade Bond0.39%$113M198
  • VCLNVirtus Duff & Phelps Clean Energy ETFSector Equity0.59%$5M189
  • VDIVirtus International Dividend ETFInternational Equity0.39%$16M121
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.